Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study-Reference-Cited by-同舟云学术

Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study

Published:2015-07-21 Issue:6 Volume:42 Page:719-730
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Sakurai Y.¹,Mori Y.¹,Okamoto H.¹,Nishimura A.¹,Komura E.¹,Araki T.¹,Shiramoto M.²

Affiliation:

1. Takeda Pharmaceutical Company Ltd.; Osaka Japan

2. Medical Co. LTA Hakata Clinic; Fukuoka Japan

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13325/fullpdf

Reference27 articles.

1. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users;Graham;Helicobacter,2002

2. Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole;Frazzoni;Aliment Pharmacol Ther,2003

3. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases;Robinson;Int J Clin Pract,2005

4. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia;Malfertheiner;Aliment Pharmacol Ther,2003

5. Review article: the control of gastric acid and Helicobacter pylori eradication;Sachs;Aliment Pharmacol Ther,2000

Cited by 288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of vonoprazan versus proton pump inhibitors in the treatment of peptic ulcer disease: a systematic review and network meta-analysis for randomized controlled trails;Frontiers in Nutrition;2024-09-05

2. Comparison of Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial;Gastroenterology;2024-09

3. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09

4. Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial;Helicobacter;2024-09

5. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27